JAMDA
December 26, 2017
Showing 7211 - 7220 of 7529 results
JAMDA
September 24, 2014
Use of Antipsychotic Drugs Among Residents With Dementia in European Long-Term Care Facilities: Results From the SHELTER Study
Behavioral and psychological symptoms of dementia (BPSD) are common reasons for use of antipsychotic drugs among older individuals with dementia. These drugs are not approved for such use and both the Food and Drug Administration and European Medicines Agency have issued warnings to limit such use.
Caring for the Ages
March 31, 2017
Use of Antipsychotics Does Not Reduce Delirium Symptom Scores
JAMDA
August 5, 2023
Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiovascular benefits, whereas thiazolidinediones (TZDs) and sulfonylureas (SUs) increase cardiovascular risk. The objective of this study was to describe the use of SGLT-2is, GLP-1RAs, TZD...
JAMDA
September 1, 2016
Use of Frailty in Deciding Clinical Treatment Goals for Chronic Disease in Elderly Patients in the Community
JAMDA
May 21, 2020
Use of Gerontechnology to Assist Older Adults to Cope with the COVID-19 Pandemic
JAMDA
April 18, 2023
Use of Home-Based Clinical Care and Long-Term Services and Supports Among Homebound Older Adults
Describe use of home-based clinical care and home-based long-term services and supports (LTSS) using a nationally representative sample of homebound older Medicare beneficiaries.
JAMDA
July 5, 2017
Use of Medical Orders for Scope of Treatment for Heart Failure Patients During Postacute Care in Skilled Nursing Facilities
Individuals with heart failure (HF) who are hospitalized and admitted to skilled nursing facilities (SNFs) are at high risk for rehospitalization and death. The care preferences of this high-risk population have not been studied.
JAMDA
April 18, 2017
Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia
To investigate the prevalence and factors associated with the use of medications of questionable benefit throughout the final year of life of older adults who died with dementia.
JAMDA
March 14, 2025